Target intelligence / Profile preview

Exostosin like glycosyltransferase 2 pseudogene 1 (EXTL2P1)

Target
EXTL2P1
Molecular classification
Other (Pseudogene)
01

Overview

EXTL2P1 is described as a pseudogene of exostosin-like glycosyltransferase 2[1]. Pseudogenes are genomic DNA sequences similar to functional genes but generally non-functional; they do not produce active protein products and typically have no direct biological activity. Pseudogenes like EXTL2P1 do not serve as therapeutic targets, do not encode active enzymes, receptors, or proteins, and are seldom considered in drug development or disease biology. There is no evidence from the current literature or curated databases to support EXTL2P1 as a protein, receptor, enzyme, or any other biomedically relevant target. The protein-coding gene in this family is EXTL2 ("Exostosin-like glycosyltransferase 2")[8][9][10]. EXTL2P1 does not encode a protein and is not used as a target in therapeutics or considered functionally relevant by available evidence[1]. Most drugs, disease roles, and molecular classifications associated with the EXT family pertain to the actual gene products (like EXTL2, EXT2, EXT1), not to pseudogenes such as EXTL2P1. If you intended a functional target, please search for "Exostosin-like glycosyltransferase 2" (EXTL2) rather than "EXTL2P1".

Beyond the preview

Go deeper on Exostosin like glycosyltransferase 2 pseudogene 1 (EXTL2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exostosin like glycosyltransferase 2 pseudogene 1 (EXTL2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call